Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cross

Showing results (361-370 of 595) with videos related to

Pageof 60
Sort By:
Haematologica|August 10, 2012
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangementsAndrew Chase, Catherine Bryant, Joannah Score, et al.
Cancer Research|October 20, 2004
p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorderFrancis H Grand, Sonja Burgstaller, Thomas Kühr, et al.
Genes, Chromosomes & Cancer|March 23, 2004
Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndromeEffie K Grand, Francis H Grand, Andrew J Chase, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 24, 2003
A consensus development approach to define national research priorities in bone metastases: proceedings from NCIC CTG workshopJ Wu, A Bezjak, E Chow, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|July 27, 2024
Odorant transport in a hagfishTodor G Cross, Olivia C Mayo, Graham S Martin, et al.
Leukemia|August 28, 2009
Harmonization of molecular monitoring of CML therapy in EuropeM C Müller, N C P Cross, P Erben, et al.
Leukemia Research|September 27, 2005
A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapyLing Yan Zhang, Matthew L Smith, Beate Schultheis, et al.
British Journal of Haematology|January 21, 2010
Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasmsClaire Hidalgo-Curtis, Jane F Apperley, Allistair Stark, et al.
Blood Advances|January 30, 2020
Treatment-free remission in FIP1L1-PDGFRA-positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuationGeorgia Metzgeroth, Juliana Schwaab, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|February 16, 2010
Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemiaChristoph Walz, David Grimwade, Susanne Saussele, et al.
Pageof 60

Showing results (361-370 of 595) with videos related to

Sort By:
Pageof 60
Haematologica|August 10, 2012
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangementsAndrew Chase, Catherine Bryant, Joannah Score, et al.
Cancer Research|October 20, 2004
p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorderFrancis H Grand, Sonja Burgstaller, Thomas Kühr, et al.
Genes, Chromosomes & Cancer|March 23, 2004
Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndromeEffie K Grand, Francis H Grand, Andrew J Chase, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 24, 2003
A consensus development approach to define national research priorities in bone metastases: proceedings from NCIC CTG workshopJ Wu, A Bezjak, E Chow, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|July 27, 2024
Odorant transport in a hagfishTodor G Cross, Olivia C Mayo, Graham S Martin, et al.
Leukemia|August 28, 2009
Harmonization of molecular monitoring of CML therapy in EuropeM C Müller, N C P Cross, P Erben, et al.
Leukemia Research|September 27, 2005
A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapyLing Yan Zhang, Matthew L Smith, Beate Schultheis, et al.
British Journal of Haematology|January 21, 2010
Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasmsClaire Hidalgo-Curtis, Jane F Apperley, Allistair Stark, et al.
Blood Advances|January 30, 2020
Treatment-free remission in FIP1L1-PDGFRA-positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuationGeorgia Metzgeroth, Juliana Schwaab, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|February 16, 2010
Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemiaChristoph Walz, David Grimwade, Susanne Saussele, et al.
Pageof 60